STOCK TITAN
  1. Home
  2. News
  3. REGN

Regeneron Pharmaceuticals, Inc. - REGN STOCK NEWS

IMPACT
SENTIMENT
REGN : Nasdaq CTMX : Nasdaq
Regeneron and CytomX Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
IMPACT
SENTIMENT
REGN : Nasdaq SNY : Nasdaq
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP for the Treatment of Prurigo Nodularis
IMPACT
SENTIMENT
REGN : Nasdaq
Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
IMPACT
SENTIMENT
REGN : Nasdaq
Aflibercept 8 mg Late-breaking Data Presented at Retina Society in Diabetic Macular Edema and Wet Age-related Macular Degeneration
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Announces Investor Conference Presentations
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Presents New Data at ASH from Advancing Hematology Pipeline across Multiple Blood Cancers and Disorders
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Reports Third Quarter 2022 Financial and Operating Results
IMPACT
SENTIMENT
REGN : Nasdaq
Inmazeb™ (atoltivimab, maftivimab, and odesivimab-ebgn) Wins Prestigious 2022 Prix Galien USA Best Biotechnology Product Award
IMPACT
SENTIMENT
REGN : Nasdaq
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA® (aflibercept) Injection
IMPACT
SENTIMENT
REGN : Nasdaq
Immune-Onc Therapeutics Initiates Expansion Cohorts for IO-108 and Enters into Clinical Supply Agreement with Regeneron
Stock REGN logo
Regeneron Pharmaceuticals, Inc.

Nasdaq:REGN

REGN Rankings

#141 Ranked by Market Cap
#1795 Ranked by Stock Gains
N/A Ranked by Dividends

REGN Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Tarrytown

About REGN

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.